Dalia Rafat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Dalia Rafat has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Tabassum Nawab
Department of Community Medicine, Faculty of Medicine, Jawaharlal Nehru Medical College, AMU, Aligarh, India
5 shared publicationsShamsi Khalid
Interdisciplinary Biotechnology Unit, Faculty of Life Sciences, AMU, Aligarh, India
3 shared publicationsAnubha Agrawal
Department of Obstetrics & Gynaecology, Faculty of Medicine, Jawaharlal Nehru Medical College, AMU, Aligarh, India
2 shared publicationsAsad U. Khan
Interdisciplinary Biotechnology Unit, Faculty of Life Sciences, AMU, Aligarh, India
2 shared publicationsSunita Singh
Department of Obstetrics & Gynaecology, Faculty of Medicine, Jawaharlal Nehru Medical College, AMU, Aligarh, India
2 shared publicationsAsad U
1 shared publication
Latest Publications
- 17 January 2025
- Published by Springer Nature in The Journal of Obstetrics and Gynecology of India
- Vol. 75 (S1) , 494-503
Impact of Glycemic Variability on Vaginal Flora Alterations and Concomitant Antimicrobial Resistance During Pregnancy: Implications for Fetomaternal Outcomes
Purpose Vaginal flora alterations (AVF) have been implicated in both health and disease states. Few studies have looked at the connection between AVF and adverse fetomaternal outcomes(AFMOs), and even fewer have assessed their concurrent link with gestational diabetes mellitus (GDM). Therefore, this study investigated the association between AVF and GDM and their impact on AFMOs. In addition, we assessed the antimicrobial resistance(AMR) of isolated pathogens and sought to identify the associated risk factors. Methods This prospective, cross-sectional study was conducted among 640 pregnant women; divided into two groups, GDM and non-GDM. We administered standardized questionnaires to collect data regarding sociodemographic and clinical characteristics; collected vaginal samples at 26–38 weeks for Nugent scoring and determination of bacterial and fungal species; assessed AMR of the isolated pathogens and followed up patients for assessment of AFMOs. Results We found AVF in 47.5% of participants, with 36.6% having single AVF and 10.9% mixed AVF. There was a significantly higher occurrence of all studied AVF subtypes in GDM group. We noted high prevalence of AMR and MDR among isolated pathogens. We also found association of AFMO with different AVF subtypes, with higher prevalence of AFMOs among participants with mixed AVF. Conclusion The impact of AVF on AFMOs, along with their association with hyperglycemia; provides a potential avenue for working on minimizing AFMOs, which will eventually contribute toward improving the health of both the women and their offspring. The high prevalence of AVF and AMR in this study, calls for effective infection control and stewardship programmes.
- 17 January 2025
- Published by Springer Nature in The Journal of Obstetrics and Gynecology of India
- Vol. 75 (S1) , 494-503
Impact of Glycemic Variability on Vaginal Flora Alterations and Concomitant Antimicrobial Resistance During Pregnancy: Implications for Fetomaternal Outcomes
Purpose Vaginal flora alterations (AVF) have been implicated in both health and disease states. Few studies have looked at the connection between AVF and adverse fetomaternal outcomes(AFMOs), and even fewer have assessed their concurrent link with gestational diabetes mellitus (GDM). Therefore, this study investigated the association between AVF and GDM and their impact on AFMOs. In addition, we assessed the antimicrobial resistance(AMR) of isolated pathogens and sought to identify the associated risk factors. Methods This prospective, cross-sectional study was conducted among 640 pregnant women; divided into two groups, GDM and non-GDM. We administered standardized questionnaires to collect data regarding sociodemographic and clinical characteristics; collected vaginal samples at 26–38 weeks for Nugent scoring and determination of bacterial and fungal species; assessed AMR of the isolated pathogens and followed up patients for assessment of AFMOs. Results We found AVF in 47.5% of participants, with 36.6% having single AVF and 10.9% mixed AVF. There was a significantly higher occurrence of all studied AVF subtypes in GDM group. We noted high prevalence of AMR and MDR among isolated pathogens. We also found association of AFMO with different AVF subtypes, with higher prevalence of AFMOs among participants with mixed AVF. Conclusion The impact of AVF on AFMOs, along with their association with hyperglycemia; provides a potential avenue for working on minimizing AFMOs, which will eventually contribute toward improving the health of both the women and their offspring. The high prevalence of AVF and AMR in this study, calls for effective infection control and stewardship programmes.
- Open Access
- 18 October 2024
- Published by Wolters Kluwer Health in Journal of Family Medicine and Primary Care
- Vol. 13 (10) , 4399-4405
Gestational weight gain and body mass index in Asian Indian women: Impact of timing and amount on fetomaternal outcomes
Background: The aim of the study was to describe pre-pregnancy body mass index (BMI), total gestational weight gain (TGWG), and trimester-specific gestational weight gain (TSGWG) among Asian Indians and examine their association with adverse fetomaternal outcomes (AFMO). Methods: Using a prospective cohort study design, 557 pregnant women were recruited in the first trimester and followed up until delivery. Maternal BMI, TGWG and TSGWG were assessed and categorised according to the World Health Organisation (WHO) Asia Pacific BMI guidelines and the Institute of Medicine (IOM) recommendations, respectively. Maternal clinical characteristics and pregnancy and neonatal outcomes were assessed to predict AFMO. Logistic regression models in univariate and multivariate analysis were performed to estimate the odds ratios (OR) and 95% confidence intervals (CI). Results: The median BMI was 23.5 kg/m2. Moreover, 24.6% were overweight and 31.2% were obese, according to WHO Asia Pacific BMI cut points. The mean TGWG was 10.8 ± 1.9 kg and the mean TSGWG in the first, second and third trimesters were 1.7 ± 0.7 kg, 4.3 ± 1.1 kg and 4.8 ± 1.2 kg, respectively. We found a significant association of BMI, TGWG and TSGWG with various AFMO. Furthermore, excess third-trimester GWG has been demonstrated as a predictor of adverse maternal outcomes like hypertension and gestational diabetes mellitus. Conclusions: Our study reinforces the importance of optimal BMI and TGWG and further emphasises on assessment of TSGWG, which allows for early diagnosis of weight deviations, when prompt interventions can still improve pregnancy outcomes. We also suggest the adoption of BMI categories and GWG recommendations, specific to the socio-demographic characteristics of the population, to optimise the prevention, early diagnosis, and timely management of AFMO.
- 18 October 2024
- Published by Wolters Kluwer Health in Journal of Family Medicine and Primary Care
- Vol. 13 (10) , 4399-4405
Open AccessGestational weight gain and body mass index in Asian Indian women: Impact of timing and amount on fetomaternal outcomes
Background: The aim of the study was to describe pre-pregnancy body mass index (BMI), total gestational weight gain (TGWG), and trimester-specific gestational weight gain (TSGWG) among Asian Indians and examine their association with adverse fetomaternal outcomes (AFMO). Methods: Using a prospective cohort study design, 557 pregnant women were recruited in the first trimester and followed up until delivery. Maternal BMI, TGWG and TSGWG were assessed and categorised according to the World Health Organisation (WHO) Asia Pacific BMI guidelines and the Institute of Medicine (IOM) recommendations, respectively. Maternal clinical characteristics and pregnancy and neonatal outcomes were assessed to predict AFMO. Logistic regression models in univariate and multivariate analysis were performed to estimate the odds ratios (OR) and 95% confidence intervals (CI). Results: The median BMI was 23.5 kg/m2. Moreover, 24.6% were overweight and 31.2% were obese, according to WHO Asia Pacific BMI cut points. The mean TGWG was 10.8 ± 1.9 kg and the mean TSGWG in the first, second and third trimesters were 1.7 ± 0.7 kg, 4.3 ± 1.1 kg and 4.8 ± 1.2 kg, respectively. We found a significant association of BMI, TGWG and TSGWG with various AFMO. Furthermore, excess third-trimester GWG has been demonstrated as a predictor of adverse maternal outcomes like hypertension and gestational diabetes mellitus. Conclusions: Our study reinforces the importance of optimal BMI and TGWG and further emphasises on assessment of TSGWG, which allows for early diagnosis of weight deviations, when prompt interventions can still improve pregnancy outcomes. We also suggest the adoption of BMI categories and GWG recommendations, specific to the socio-demographic characteristics of the population, to optimise the prevention, early diagnosis, and timely management of AFMO.
- Open Access
- 27 November 2023
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology: X
- Vol. 21, 100263
Bacterial abundance and antimicrobial resistance patterns of uropathogens among pregnant women with asymptomatic bacteriuria: Association with glycemic status
- 27 November 2023
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology: X
- Vol. 21, 100263
Open AccessBacterial abundance and antimicrobial resistance patterns of uropathogens among pregnant women with asymptomatic bacteriuria: Association with glycemic status
- Open Access
- 16 March 2022
- Published by IntechOpen
Gestational Diabetes Mellitus and Maternal Microbiome Alterations
The maternal microbiome has been identified as a critical driver for a variety of important mother and child health outcomes. Studies have demonstrated changes in maternal microbiome during pregnancy. These changes may have an impact on the maternal metabolic profile, play a role in pregnancy problems, and contribute to the metabolic and immunological health of the offspring. Gestational diabetes mellitus is a major challenge for prenatal healthcare providers, not only because of the negative short and long-term effects on the mother’s and baby’s health, but also because its aetiology has been poorly understood till now. The developing link between maternal microbiome and metabolic disorders in pregnancy can be offered as a new target in their prevention and treatment, as well as in reducing their negative health outcomes; however, there has been very little research done on this. Diabetes’ impact on site-specific maternal microbiome alterations during pregnancy is similarly poorly understood. Given the rising prevalence of diabetes in pregnancy and the potential importance of the maternal microbiome, more research is needed to understand and rigorously examine how metabolic disorders in pregnancy affect the pregnancy-associated microbiome, as well as whether these microbial alterations affect the health of the mother and her offspring.
- 16 March 2022
- Published by IntechOpen
Open AccessGestational Diabetes Mellitus and Maternal Microbiome Alterations
The maternal microbiome has been identified as a critical driver for a variety of important mother and child health outcomes. Studies have demonstrated changes in maternal microbiome during pregnancy. These changes may have an impact on the maternal metabolic profile, play a role in pregnancy problems, and contribute to the metabolic and immunological health of the offspring. Gestational diabetes mellitus is a major challenge for prenatal healthcare providers, not only because of the negative short and long-term effects on the mother’s and baby’s health, but also because its aetiology has been poorly understood till now. The developing link between maternal microbiome and metabolic disorders in pregnancy can be offered as a new target in their prevention and treatment, as well as in reducing their negative health outcomes; however, there has been very little research done on this. Diabetes’ impact on site-specific maternal microbiome alterations during pregnancy is similarly poorly understood. Given the rising prevalence of diabetes in pregnancy and the potential importance of the maternal microbiome, more research is needed to understand and rigorously examine how metabolic disorders in pregnancy affect the pregnancy-associated microbiome, as well as whether these microbial alterations affect the health of the mother and her offspring.
- 1 February 2022
- Published by JCDR Research and Publications in Journal of Clinical and Diagnostic Research
To Assess Knowledge and Perception of Pregnant Women Regarding Excess Maternal Weight, Gestational Weight Gain and their Impact on Foetomaternal Outcomes: A Cross-sectional Study
Introduction: Well recognised associations exist between maternal obesity, Gestational Weight Gain (GWG) and adverse health outcomes for mothers and their babies. Studies regarding women’s knowledge of the risks of excess maternal weight and GWG are limited in both the populations assessed and also in their description of knowledge. Aim: To examine women’s perception of their own weight in pregnancy and to assess pregnant women’s knowledge of complications of obesity and excess GWG and ways to manage the appropriate GWG. Materials and Methods: A total of 216 pregnant women were recruited in this cross-sectional study from the antenatal clinic of Jawaharlal Nehru Medical College and Hospital, Aligarh, India between May and June 2018. Data was collected using an interviewer administered prestructured and pretested questionnaire. Statistical analyses were performed using Statistical Package for the Social Sciences (SPSS) version 20.0. Results: Mean age of study population was 25.02±4.6 years. Mean Body Mass Index (BMI) was 24.55±4.07 kg/m2 . Frequent misclassification of their own BMI and inappropriate estimation of GWG by pregnant women was found in the present study. Overweight and obese women were more prone to inaccurate self-classification as 68.7% of overweight women and 62.5% of obese women underestimated their weight. Women had optimum knowledge for complications of obesity (69.4%) to mothers but knowledge is poor regarding complications to babies (45.5%). Also, awareness is significantly lower in obese women as compared to normal weight women p<0.05. Conclusion: Notable deficiencies in the knowledge and perceptions of pregnant women regarding their weight, obesity, GWG and their impact on foetomaternal outcomes were found in the present study. Bridging this knowledge gap would be an important step towards improving short and long-term adverse maternal and perinatal outcomes.
- 1 February 2022
- Published by JCDR Research and Publications in Journal of Clinical and Diagnostic Research
To Assess Knowledge and Perception of Pregnant Women Regarding Excess Maternal Weight, Gestational Weight Gain and their Impact on Foetomaternal Outcomes: A Cross-sectional Study
Introduction: Well recognised associations exist between maternal obesity, Gestational Weight Gain (GWG) and adverse health outcomes for mothers and their babies. Studies regarding women’s knowledge of the risks of excess maternal weight and GWG are limited in both the populations assessed and also in their description of knowledge. Aim: To examine women’s perception of their own weight in pregnancy and to assess pregnant women’s knowledge of complications of obesity and excess GWG and ways to manage the appropriate GWG. Materials and Methods: A total of 216 pregnant women were recruited in this cross-sectional study from the antenatal clinic of Jawaharlal Nehru Medical College and Hospital, Aligarh, India between May and June 2018. Data was collected using an interviewer administered prestructured and pretested questionnaire. Statistical analyses were performed using Statistical Package for the Social Sciences (SPSS) version 20.0. Results: Mean age of study population was 25.02±4.6 years. Mean Body Mass Index (BMI) was 24.55±4.07 kg/m2 . Frequent misclassification of their own BMI and inappropriate estimation of GWG by pregnant women was found in the present study. Overweight and obese women were more prone to inaccurate self-classification as 68.7% of overweight women and 62.5% of obese women underestimated their weight. Women had optimum knowledge for complications of obesity (69.4%) to mothers but knowledge is poor regarding complications to babies (45.5%). Also, awareness is significantly lower in obese women as compared to normal weight women p<0.05. Conclusion: Notable deficiencies in the knowledge and perceptions of pregnant women regarding their weight, obesity, GWG and their impact on foetomaternal outcomes were found in the present study. Bridging this knowledge gap would be an important step towards improving short and long-term adverse maternal and perinatal outcomes.
- 24 September 2021
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 158 (1) , 70-78
Association of vaginal dysbiosis and gestational diabetes mellitus with adverse perinatal outcomes
Objective: Gestational diabetes mellitus (GDM) is associated with adverse perinatal outcomes and is an independent risk factor for vaginal dysbiosis. Understanding the vaginal microbiota in health and disease is essential to screen, detect, and manage complications of pregnancy. Therefore, the aims of the present study were to assess and compare vaginal dysbiosis in pregnancy in women with and without GDM and examine its impact on perinatal outcomes in our population.Methods: The present study was a prospective cohort study recruiting pregnant women. The subjects were divided into two groups (GDM and non‐GDM) and were followed until delivery to assess fetomaternal outcomes. Vaginal samples were collected at 24–28 weeks and 34–38 weeks for Nugent scoring and determination of bacterial and fungal species.Results: The study recruited 502 pregnant women, with a final assessment of 320 mother–infant pairs (GDM n = 134; non‐GDM n = 186). We found a significant association of vaginal dysbiosis with GDM and adverse perinatal outcomes. Significant differences were also seen in status of infection and its trimester‐wise changes in relation to hyperglycemia.Conclusion: By defining an association of vaginal dysbiosis with GDM and its correlation with perinatal outcomes, the present study calls for exploitation of this potential association as a new target in the prevention and treatment of GDM and in alleviating their undesired maternal and infant outcomes.
- 24 September 2021
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 158 (1) , 70-78
Association of vaginal dysbiosis and gestational diabetes mellitus with adverse perinatal outcomes
Objective: Gestational diabetes mellitus (GDM) is associated with adverse perinatal outcomes and is an independent risk factor for vaginal dysbiosis. Understanding the vaginal microbiota in health and disease is essential to screen, detect, and manage complications of pregnancy. Therefore, the aims of the present study were to assess and compare vaginal dysbiosis in pregnancy in women with and without GDM and examine its impact on perinatal outcomes in our population.Methods: The present study was a prospective cohort study recruiting pregnant women. The subjects were divided into two groups (GDM and non‐GDM) and were followed until delivery to assess fetomaternal outcomes. Vaginal samples were collected at 24–28 weeks and 34–38 weeks for Nugent scoring and determination of bacterial and fungal species.Results: The study recruited 502 pregnant women, with a final assessment of 320 mother–infant pairs (GDM n = 134; non‐GDM n = 186). We found a significant association of vaginal dysbiosis with GDM and adverse perinatal outcomes. Significant differences were also seen in status of infection and its trimester‐wise changes in relation to hyperglycemia.Conclusion: By defining an association of vaginal dysbiosis with GDM and its correlation with perinatal outcomes, the present study calls for exploitation of this potential association as a new target in the prevention and treatment of GDM and in alleviating their undesired maternal and infant outcomes.
- Open Access
- 1 January 2018
- Published by Medwin Publishers in Diabetes & Obesity International Journal
- Vol. 1 (1)
Biomarkers for Assessing Glycemic Control in Pregnancy
MedWin is an open access Publishers on the latest research in the fields of Dental, pediatrics, diabetes, ophthalmology, Orthopedics, Biotechnology, virology.
- 1 January 2018
- Published by Medwin Publishers in Diabetes & Obesity International Journal
- Vol. 1 (1)
Open AccessBiomarkers for Assessing Glycemic Control in Pregnancy
MedWin is an open access Publishers on the latest research in the fields of Dental, pediatrics, diabetes, ophthalmology, Orthopedics, Biotechnology, virology.
- Open Access
- 22 November 2016
- Published by Juniper Publishers in Journal of Gynecology and Womens Health
- Vol. 1 (5)
Hepatitis B in Pregnancy: Challenges and Solutions
- 22 November 2016
- Published by Juniper Publishers in Journal of Gynecology and Womens Health
- Vol. 1 (5)
Open AccessHepatitis B in Pregnancy: Challenges and Solutions
- 16 September 2016
- Published by Springer Nature in Indian Journal of Gynecologic Oncology
- Vol. 14 (4) , 53
Vascular Hamartoma of Broad Ligament: A Rare Case Report
- 16 September 2016
- Published by Springer Nature in Indian Journal of Gynecologic Oncology
- Vol. 14 (4) , 53
Vascular Hamartoma of Broad Ligament: A Rare Case Report